Bioavailability: What Are Your Thoughts On Enhancing Bioavailability With Novel Technologies?
Pharma's Almanac
PAP-Q02-16-RT-001Apr 01, 2016
Biopharma’s Ascendant Supply Chain Reveals its Present Potential & Future Promise
Steve Kuehn; Cynthia A. Challener, Ph.D.; Emilie Branch
Nice Insight
PAP-Q02-16-FA-001Apr 01, 2016
Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies
Oliver Technow
BIOVECTRA
PAP-Q02-16-CL-007Apr 01, 2016
Brammer Bio: Manufacturing Personalized
Mark Allen
Nice Insight
PAP-Q02-16-DL-001Apr 01, 2016
Investment Recovery for Pharma Equipment – Part 1
Matt Hicks
Federal Equipment Company
PAP-Q02-16-CL-006Apr 01, 2016
Innovation at the Heart of Biopharmaceutical Industry Growth
Nigel Walker
Nice Insight
PAP-Q02-16-NO-001Apr 01, 2016
Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals
Syed T. Husain
Alcami
PAP-Q02-16-CL-011Apr 01, 2016
Process Safety Evaluations Crucial to Successful CDMO Operations
Vince Ammoscato, M.Sc.; Sean Lapekas
Ash Stevens
PAP-Q02-16-CL-009Apr 01, 2016
Scale-Down Models: An Indispensable Tool to Biopharmaceutical Process Development
John Moscariello, Ph.D.
PAP-Q02-16-CL-008Apr 01, 2016
Quality Culture Wins Over Compliance
Guy Villax
Hovione
PAP-Q02-16-CL-001Apr 01, 2016
Achieving Large-Scale Cell and Gene Therapy Manufacturing
Mark Bamforth; Richard Snyder, Ph.D.; Steve Kasok
Arranta Bio
PAP-Q02-16-CL-010Apr 01, 2016
Alcami: Connected at Every Level
Mark Allen
Nice Insight
PAP-Q02-16-DL-002Apr 01, 2016
Integrating Drug Discovery and Development to Improve Efficiency and Candidate Success
Cyrus K. Mirsaidi
Sundia
PAP-Q02-16-CL-005Apr 01, 2016
Nice Insight Pharmaceutical Equipment 2016 Annual Study
KshitiJ (TJ) Ladage
Nice Insight
PAP-Q02-16-NI-003Apr 01, 2016
A Holistic Interpretation of Commitment to Quality
Oriol Prat
Grifols
PAP-Q02-16-CL-012Apr 01, 2016
Accelerating Drug Development and Manufacturing with Engineered Enzymes
Rob Wilson, Ph.D.
Codexis
PAP-Q02-16-CL-004Apr 01, 2016
Dose and Form Matter: Future of Care Demands Optimal Drug Delivery
Kevin Haehl
Unither Pharmaceuticals
PAP-Q02-16-CL-003Apr 01, 2016
Enabling Right-First-Time Tech Transfer with Effective Scale-Down Modeling
Erich Blatter, Ph.D.
GSK Contract Manufacturing
PAP-Q02-16-CL-002Apr 01, 2016
Research Database Recommendations
Guy Tiene
Nice Insight
PAP-Q02-16-NI-001Apr 01, 2016
From Qualified to Ideal: The Importance of Partnership
Guy Tiene
Nice Insight
PAP-Q02-16-VP-001Apr 01, 2016